Thomson Snell & Passmore advises Centron Diagnostics Limited on its technology sale to international US company

Thomson Snell & Passmore has advised Centron Diagnostics Ltd, a spin-out company from King’s College London, in relation to the sale of its central blood pressure monitoring technology and assets to SunTech Medical Inc, a global leader in clinical-grade, non-invasive blood pressure measurement solutions.

The technology was developed through research at King’s College London and commercialised via Centron and will now be available to health care workers and patients through the sale to SunTech.

Centron Diagnostics was spun out of King’s College London in 2010 with investment from its founders and from Guy’s and St Thomas’ Charity. King’s College London licenced the patented technology to Centron Diagnostics for development and commercialisation, supporting the company in its early stages whilst retaining a shareholding. Certain of the underpinning research was funded by the British Heart Foundation.

The corporate team at Thomson Snell & Passmore was led by Joanne Gallagher(Partner) who assisted with the intellectual property, contractual and cross-border considerations of the transaction.